title: Assessment of hyperacute rejection in a rat-to-primate cardiac xenograft model.
abstract: We studied a rat-to-cynomolgous monkey model for xenotransplantation of vascularized organs and found that a rat heart was rejected in 5.5 +/- 1.4 min (n = 10). This hyperacute rejection (HAR) was consistent with kinetic experiments in vitro that showed damage to rat endothelial cells (ECs) after 3 min of incubation with primate serum. Histopathology and ultrastructural analysis of rejected hearts showed marked EC damage and early adherence of platelets and polymorphonuclear leukocytes to the endothelium. Immunohistochemical analysis revealed deposition along endothelial surfaces of IgG, IgM, and complement (C) components of the classical but not the alternative pathway, suggesting that, as in the pig-to-primate model, HAR is mediated by the binding of recipient xenogeneic natural antibodies and C activation. The effect of C depletion on xenograft survival was evaluated in two recipients that were treated with cobra venom factor (CVF). CVF caused complete C inactivation, demonstrated by lack of serum hemolytic activity and C-dependent EC cytotoxicity at engraftment and until the animals died. The rat cardiac transplants survived for at least 9 hr and 77 hr. Histology showed massive interstitial hemorrhage, edema, and cellular infiltration with scanty fibrin deposits. These results in CVF-treated recipient monkeys indicate that C activation mediates the development of HAR in this rat-to-primate model. We suggest that the model may be of interest as an alternative to the more expensive and time-consuming pig-to-primate model for testing the efficacy of transgenic modification of donor organs to prolong xenograft survival and for studying mechanisms of discordant xenograft rejection.
authors.affiliation: Laboratoire de Chirurgie Expérimentale, Faculté de Médecine, Strasbourg, France.
authors.forename: A
authors.initials: A
authors.lastname: Azimzadeh
authors.forename: P
authors.initials: P
authors.lastname: Wolf
authors.forename: A P
authors.initials: AP
authors.lastname: Dalmasso
authors.forename: M
authors.initials: M
authors.lastname: Odeh
authors.forename: J P
authors.initials: JP
authors.lastname: Beller
authors.forename: M
authors.initials: M
authors.lastname: Fabre
authors.forename: B
authors.initials: B
authors.lastname: Charreau
authors.forename: K
authors.initials: K
authors.lastname: Thibaudeau
authors.forename: J
authors.initials: J
authors.lastname: Cinqualbre
authors.forename: J P
authors.initials: JP
authors.lastname: Soulillou
authors.forename: I
authors.initials: I
authors.lastname: Anegon
mesh_terms: D000818:Animals; D002199:Capillary Permeability; D004546:Elapid Venoms / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000276:immunology / Q000503:physiopathology; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D008252:Macaca fascicularis; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D014183:Transplantation, Heterologous
chemical_list: D004546:Elapid Venoms; C016310:cobra venom factor